PENZBERG, Germany & SAN CARLOS, Calif.--(BUSINESS WIRE)--Roche Applied Science and NuGEN Technologies, Inc., a privately held company that develops and commercializes highly sensitive nucleic acid amplification and labeling systems, announced today an agreement that will enable Roche to market and sell an RNA amplification product based on the technology of NuGEN’s proprietary WT-Ovation™. The new product, called LightCycler® RNA Pre-Amplification Kit, is scheduled to be released in the third quarter of 2008.
